UV Spectrophotometric Determination of Norethisterone in Tablets
Rama Chandra Reddy A.*, Roshna K., P. Mohanraj, Kulanthavel T. M, SaravananV. S. and Ganesh V.
Department of Pharmaceutical Analysis, The Erode College of Pharmacy, Veppampalayam, Erode – 638112, TN
*Corresponding Author E-mail: ramachandra.ecp@gmail.com
ABSTRACT:
A new simple, sensitive, precise and economical spectrophotometric method of analysis for a bulk drug was developed and validated. The method employed methanol as solvent. The drug was then estimated at 270 nm. The linear regression analysis data for the calibration plots showed good linear relationship with r2 = 0.999 in the concentration range 0.5-3.0 µg/ml. The mean value of correlation coefficient, slope and intercept were 0.999, 0.0332 and 0.0002 respectively. The method was validated for precision, accuracy and recovery studies. LOD and LOQ for norethisterone was found to be 0.01987 (µg/ml) and 0.06024 (µg/ml) respectively. The method has been successfully applied in the analysis of marketed formulations.
KEYWORDS: Norethisterone; UV spectrophotometric analysis
INTRODUCTION:
Norethisterone is 17α -hydroxy-19-nor-17α -4-pregnen-20- yn-3-one1 (Fig.1).
The 19-nor-progestogen norethisterone is used as a
progestogen component in contraceptives and in continuous- and sequential combined Hormone Replacement Therapy (HRT) in postmenopausal
women. Metabolism of norethisterone in HRT target tissues may
play a role in its biological response. However, both progestogenic and antiprogestogenic effects of
norethisterone have been described on uteroglobin and progesterone
receptor expression in the uterus of progesterone-treated prepubertal
rabbits2. Moreover, estrogenic activity of norethisterone in rat uterus is mediated through 5
-reduced metabolites of norethisterone3 . Conversion of norethisterone in e.g., uterus into more estrogenic metabolites may
affect the estrogen/ progestogen balance that is the key feature of
a combined HRT. A literature survey revealed that several analytical methods were
reported for the determination of norethsterone in biological fluids including
liquid chromatography tandem mass spectrometry (LC–MS–MS)4, Voltammetry and quantification
of the contraceptive drug norethisterone in bulk form and pharmaceutical
formulation5,
Establishment of an HPLC identification system for detection of counterfeit steroidal drugs6, Highly Sensitive Analysis of Norethisterone in Human Serum by LC Coupled with Atmospheric Pressure Photoionization Tandem Mass Spectrometry7. The aim of the present work is to develop and validate an accurate, specific, economical and reproducible UV Spectrophotometric method for determination for norethisterone as bulk drug. Drug was found to be freely soluble in methanol hence this solvent was chosen for proceeding study.
MATERIALS AND METHOD:
All the absorbance measurements were made on Systronics – 2201 UV/Visible double beam spectrophotometer with 10mm matched cells. Whatman filter no. 41 was used to filter solutions. The norethisterone standard was provided by Cadila, Ahmedabad. All chemicals were of analytical grade. Methanol was purchased from Merck Ltd, Mumbai. Commercially available two formulations [primolut-N (Zota), Noritis (Cadila)] were procured from local market.
Optimization of Parameters:
It was fond that norethisterone has λmax at 270 nm by scanning of diluted solution. The selection criteria was based on the minimum strength, which gives the maximum absorbance.
Preparation of Standard Solution:
Stock standards of norethisterone was prepared by dissolving 50 mg of the compound in 100 ml of methanol to give stock concentrations of 500 µg ml. 50 mg of norethisterone accurately weighed was dissolved in about 50 ml of methanol and diluted with 100ml of the same solvent. 1ml of this solution was again diluted to 100 ml.
Fig. 1. Chemical Structure Norethisterone
Fig.2. Absorption Maximum of Norethisterone
Table 1: Summary of Optical, Regression and Validation Parameters.
|
Linearity range (µg/ml) |
0.5-3 μg/ml |
|
λmax |
270 nm |
|
Beer’s law limit (µg/ml) |
0.5-10 μg/ml |
|
Regression equation |
Y = 0.332 × -0.002 |
|
Slope |
0.332 |
|
Intercept |
0.002 |
|
Corelation coefficient |
0.999 |
|
Accuracy (%recovery) |
100-100.09 |
|
LOD (µg/ml) |
0.01987 |
|
LOQ (µg/ml) |
0.06024 |
Preparation of calibration curve:
Suitable aliquots of the standard solution of norethisterone (1.0-6.0ml) were taken into 10 ml volumetric flasks, and volume was then made up to the mark with methanol to prepare a series of standard solutions containing 0.5-3.0 µg/ml. Absorbance of the complex was measured at 270nm against blank. A calibration curve was constructed by plotting absorbance of analyte versus nominal concentration using the weighted least (1/x) regression mode.
Estimation of norethisterone in tablets:
Twenty tablets were taken and their weight was calculated. The average weight of the tablets were found out, The quantity of powder equivalent to 50 mg of northisterone were transferred to 100ml volumetric flask and mixed with 50 ml of methanol and the solution was sonicated for 10 minutes. Then the volume was made up to 100 ml with the same solvent. The solution was filtered through Whatman filter paper no. 41. From the filtrate, 1 ml was transferred to 100 ml volumetric flask and the volume was made up to 100 ml with methanol, 10 ml was transferred to 50 ml volumetric flask and the volume was made up to 50 ml with methanol. The reference standard of norethisterone was also prepared in the same way at each concentration level and absorbance was noted at 270 nm against blank.
Fig.3. Calibration Curve for Norethisterone
Table: 2. Precision of Proposed Method
|
Concentration (μg/ml) |
Concentration found on |
|||
|
Intra-day |
Inter-day |
|||
|
S.D |
%RSD |
S.D |
%RSD |
|
|
1 2 3 |
0.001260 0.001291 0.001722 |
0.6666 0.1945 0.1722 |
0.002449 0.002179 0.002291 |
0.7558 0.3286 0.2308 |
Table 3: Analysis of Norethisterone in Tablet Formulations
|
S. No |
Brand |
Label claim (mg/tablet) |
Amount found (mg/tablet) |
% Recovery |
% RSD |
|
1. 2. |
Primolut-N Noritis |
5 5 |
4.907 4.965 |
98.15 99.3 |
0.0342 0.0279 |
METHOD VALIDATION:
Accuracy of the method was determined by the recovery studies in the tablets formulation of the norethisterone. Recovery studies were carried out by addition of known quantities of standard drug solution to pre-analyzed sample at three different concentrations. Also the experiment was repeated three times in a day to determine intra-day precision and on three different days to determine inter-day precision. The percentage relative standard deviation (%RSD) was calculated at each concentration level. The values of method validation are given in Table 2. The proposed method obeys beer’s law in the concentration range of 0.5-3µg/ml. In this method, the correlation coefficient (r2) was found to be 0.999, the slope was 0.332 and intercept 0.002. Limit of detection (LOD) and limit of quantitation (LOQ) were calculated by repeating the blank measurements six times at 270nm. LOD and LOQ for norethisterone were found to be 0.01987 (µg/ml) and 0.06024 (µg/ml) respectively. It can be concluded that the developed method is sensitive.
RESULTS AND DISCUSSION:
The proposed method is simple and precise and do not suffer from any interference due to common excipients of tablets. Beer’s law is obeyed in concentration range of 0.5-3.0 µg/ml. Method were validated in terms of accuracy and precision. The accuracy of the methods was proved by performing recovery studies in the commercially available formulations. Values greater than 99% indicate that proposed method is accurate for the analysis of drug. The precision of the method was checked in terms of Inter-day and Intra-day, where methods were repeated on three different day and also repeated on three different time periods in same day. The results given in Table 2 shows % RSD of less than 1% at each level clearly indicate that the method is precise enough for the analysis of the drug. Summary of Optical, Regression and Validation Parameters are shown in Table 1. Commercial formulation of norethisterone tablets was successfully analyzed by the proposed and reference methods. The values obtained by the proposed and reference methods are presented in Table-3.
REFERENCES:
1. The Merck Index 2006, 14th Edition, Merck Research Laboratories. Page: 1157.
2. AM Pasapera, MA Cerbon, I Castro, R Gutierrez, I Camacho-Arroyo, GA Garcia and G Perez-Palacios. Biol Reprod. 1995; 52: 426-432.
3. C A Mendoza-Rodriguez, I Camacho-Arroyo, C A Garcia and M A Cerbon. Contraception. 1999; 59: 339-343.
4. Wu Zhuping, A Chao Zhang, A Chengdui Yang, A Xinrong Zhang and Erruoweb. The Analyst. 2000; 125: 2201-2205.
5. M M Ghoneim, A M Abushoffa, Y I Moharram and H S El-Desoky, J Pharma Biomed Anal. 2007; 43(2): 499-505.
6. Ya-Qinshi, Jing Yao, Feng Liu, Chang-Qin Hu, Jun Yuan and Shao-Hong Jin. J Pharma Biomed Anal. 2008; 46(4): 662-669.
7. Chao Zhang, Suodi Zhai and Wei Liang. Chromatographia. 2009; 69(7-8): 665-670.
8. M J Blom, M Groot Wassink, F Vanwijk, A G H Edveen. Drug Metabolism and Disposition. 2001; 29(7): 976-982.
9. F J Zeelen and E N bergink. Academic Press, NewYork, 1980; 39-48.
10. Pharmaceutical Chemistry Journal. 1998; 32(4): 217-225.
11. Zhiyong Guo, Danyi Wei, Gengxin Yin and Jinxia Zhai. Journal of Chromatography B. 2007; 856(1-2): 312-317.
12. J Christopher Walker, A David Cowan, H T Vivian James, C Y Joanne Lau and T Andrew Kicman. Steroids. 2009; 74(3): 335-340.
Received on 27.10.2009 Modified on 29.11.2009
Accepted on 24.12.2009 © AJRC All right reserved
Asian J. Research Chem. 3(1): Jan.-Mar. 2010; Page 172-174